(S (S (VP (VBG Predicting) (NP (NP (JJ drug-target) (NNS interactions)) (PRN (-LRB- -LRB-) (NP (NNP DTI)) (-RRB- -RRB-))))) (VP (VBZ is) (NP (NP (DT an) (JJ essential) (NN part)) (PP (IN of) (NP (NP (DT the) (NN drug) (NN discovery) (NN process)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (DT an) (JJ expensive) (NN process)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN time) (CC and) (NN cost)))))))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (S (VP (VBG reducing) (NP (NNP DTI) (NN cost)))) (VP (MD could) (VP (VB lead) (PP (TO to) (NP (NP (JJ reduced) (NN healthcare) (NNS costs)) (PP (IN for) (NP (DT a) (NN patient))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT a) (ADJP (RB precisely) (VBN learned)) (NN molecule) (NN representation)) (PP (IN in) (NP (DT a) (NNP DTI) (NN model)))) (VP (MD could) (VP (VB contribute) (PP (TO to) (S (VP (VBG developing) (NP (NP (JJ personalized) (NN medicine)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD will) (VP (VB help) (NP (JJ many) (JJ patient) (NNS cohorts)))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (NP (DT a) (JJ new) (NN molecule) (NN representation)) (VP (VBN based) (PP (IN on) (NP (DT the) (NN self-attention) (NN mechanism))))) (, ,) (CC and) (NP (NP (DT a) (JJ new) (NNP DTI) (NN model)) (VP (VBG using) (NP (PRP$ our) (NN molecule) (NN representation)))))) (. .))
(S (NP (DT The) (NNS experiments)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NNP DTI) (NN model)) (VP (VBZ outperforms) (NP (NP (DT the) (NN state)) (PP (IN of) (NP (DT the) (NN art)))) (PP (IN by) (NP (QP (IN up) (TO to) (CD 4.9)) (NN %) (NNS points))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NN area)) (PP (IN under) (NP (DT the) (JJ precision-recall) (NN curve))))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (NP (DT a) (NN study)) (VP (VBG using) (NP (DT the) (NNP DrugBank) (NN database)))) (VP (VBZ proves) (SBAR (IN that) (S (NP (PRP$ our) (NN model)) (VP (ADVP (RB effectively)) (VBZ lists) (NP (NP (DT all) (VBN known) (NNS drugs)) (VP (VBG targeting) (NP (DT a) (JJ specific) (NN cancer) (NN biomarker)))) (PP (IN in) (NP (DT the) (JJ top-30) (NN candidate) (NN list))))))) (. .))
